ATE221879T1 - Kristalline paclitaxel hydrate - Google Patents

Kristalline paclitaxel hydrate

Info

Publication number
ATE221879T1
ATE221879T1 AT95119595T AT95119595T ATE221879T1 AT E221879 T1 ATE221879 T1 AT E221879T1 AT 95119595 T AT95119595 T AT 95119595T AT 95119595 T AT95119595 T AT 95119595T AT E221879 T1 ATE221879 T1 AT E221879T1
Authority
AT
Austria
Prior art keywords
hydrates
crystalline paclitaxel
paclitaxel
pseudopolymorph
crystalline
Prior art date
Application number
AT95119595T
Other languages
English (en)
Inventor
Robert K Perrone
Scott R Stenberg
Murray A Kaplan
Akram Saab
Shreeram Agharkar
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23396320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE221879(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE221879T1 publication Critical patent/ATE221879T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT95119595T 1994-12-13 1995-12-12 Kristalline paclitaxel hydrate ATE221879T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35512594A 1994-12-13 1994-12-13

Publications (1)

Publication Number Publication Date
ATE221879T1 true ATE221879T1 (de) 2002-08-15

Family

ID=23396320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95119595T ATE221879T1 (de) 1994-12-13 1995-12-12 Kristalline paclitaxel hydrate

Country Status (9)

Country Link
EP (1) EP0717041B2 (de)
JP (1) JPH08208636A (de)
AT (1) ATE221879T1 (de)
AU (1) AU699542B2 (de)
CA (1) CA2163837C (de)
DE (1) DE69527696T3 (de)
DK (1) DK0717041T3 (de)
ES (1) ES2181744T5 (de)
PT (1) PT717041E (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2729666A1 (fr) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
ATE278397T1 (de) † 1997-03-31 2004-10-15 Boston Scient Ltd Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
PL203300B1 (pl) * 2000-10-31 2009-09-30 Akad Medyczna Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1451168A4 (de) 2001-11-30 2005-08-24 Bristol Myers Squibb Co Paclitaxelsolvate
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US7919108B2 (en) 2006-03-10 2011-04-05 Cook Incorporated Taxane coatings for implantable medical devices
US7875284B2 (en) 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
WO2008005284A2 (en) * 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
NZ578341A (en) 2007-01-21 2011-06-30 Hemoteq Ag Method for producing a coated catheter balloon
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP2944332B1 (de) 2009-07-10 2016-08-17 Boston Scientific Scimed, Inc. Verwendung von nanokristallen für einen wirkstofffreisetzungsballon
EP2453938B1 (de) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nukleierung von wirkstofffreisetzungsballons für verbesserte kristallgrösse und -dichte
EP2611476B1 (de) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Beschichtungsverfahren für wirkstofffreisetzungsballons mit wärmeinduziertem rewrap-gedächtnis
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
CN111803698B (zh) * 2014-02-14 2022-05-27 波士顿科学国际有限公司 具有治疗剂释放的快速降解栓塞颗粒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) † 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) † 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5380916A (en) † 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
TW467896B (en) † 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes

Also Published As

Publication number Publication date
ES2181744T5 (es) 2008-03-01
PT717041E (pt) 2002-11-29
ES2181744T3 (es) 2003-03-01
CA2163837C (en) 1999-07-20
AU699542B2 (en) 1998-12-03
AU4035595A (en) 1996-06-20
EP0717041A1 (de) 1996-06-19
CA2163837A1 (en) 1996-06-14
EP0717041B1 (de) 2002-08-07
DE69527696T3 (de) 2008-04-03
DE69527696T2 (de) 2003-04-03
DK0717041T3 (da) 2002-11-25
DE69527696D1 (de) 2002-09-12
JPH08208636A (ja) 1996-08-13
EP0717041B2 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
DE69527696D1 (de) Kristalline Paclitaxel Hydrate
FI952248L (fi) Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
PL348451A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DK1200418T3 (da) Nematodicide trifluorbutener
FI956228L (fi) Sisäänhengitykseen tarkoitettuja koostumuksia
PT1193270E (pt) Pirrolobenzodiazepinas
FI963692L (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
IL149459A0 (en) Recombinant gelatins
IT1285770B1 (it) Composti corticoidei
DE69625354D1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
CA2152771A1 (en) 7-o-ethers of taxane derivatives
SE9801494D0 (sv) Novel use
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
HUP0101482A3 (en) Piperidinyl and n-amidinopiperidinyl derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
IL135634A0 (en) 5-htif agonists
EP1073447A4 (de) N1 modifizierte glycopeptide
SE9904128D0 (sv) Novel compounds
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0717041

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0717041

Country of ref document: EP

REN Ceased due to non-payment of the annual fee